Composition comprising antisense oligonucleotide and use thereof for treatment of duchenne muscular dystrophy

MYPI2025000949A0Undetermined Publication Date: 2019-12-26NIPPON SHINYAKU CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000949
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-10-01
Filing Date
2019-06-26
Publication Date
2019-12-26
Patent Text Reader

Abstract

The present invention relates to a composition containing an antisense oligonucleotide, and the use thereof to treat Duchenne muscular dystrophy. The present invention particularly relates to the above-described composition that is effective for the treatment of Duchenne muscular dystrophy when it is administered at a dose for the treatment, and the use thereof.
Need to check novelty before this filing date? Find Prior Art